(ü 345) |
|
|
|
|
|
|
[] GC, '-HER2-CAR ȣ Ư'
GC(ǥ ڴ) -HER2 ü ̸ ϴ CAR (Ű ü) ȣ Ư㸦 ߴٰ 20 .̹ Ư㸦 NK Ȱȭ ȭ CAR ü -HER2
ϼ
2022-01-20
|
|
|
|
|
|
|
[] GC, ġ ũ
캴 ġ ü GC(ǥ ö) (Լ) ġ ũ ߴٰ 17 . 츣佺 ̷ ϴ ȯ, ѹ Ǹ ü ̷ ´. ̷
ϼ
2022-01-17
|
|
|
|
|
[] , DZ μ ü
ݷ Ż コɾ DZб μӵ KUϼͿ üߴٰ 12 .̹ ݷ ܰ ġḦ ȣ ϸ ˻缭 ̴.
ϼ
2022-01-12
|
|
|
|
|
[] GC, ԷŸ ƽ ۳ 500
캴 ġ ü GC(ǥ ö) ڻ Է ŸB ƽ 500 ߴٰ 11 .ƽ ǰ 2017 100 ų 50% ĸ ؿԴ. GC
ϼ
2022-01-11
|
|
|
|
|
[] GC, ̹ü 'ε '
GC(ǥ ڴ) ε Rivaara Immune Private Limited( Rivaara) 鿪 ġ ̹ü(Immuncell-LC) üߴٰ 4 .̹ ̹ü ù ° ؿ
ϼ
2022-01-05
|
|
|
|
|
[] , ʷϻŸ ũ Ƽ Ȳ
캴 ġ ü ۷ι コɾ (Sanofi) ѱ -ƺƼ ڸ(ǥ , ) Ƹٿ, , ̽ Բϴ 2021 Ư ũ 2, ʷϻŸ ũ Ƽ
ϼ
2022-01-05
|
|
|
|
|
[] ö GC ǥ, " ȭ õ "
캴 ġ ü GC(ǥ ö) γ(Ҵ) ظ ¾ 2022 ų縦 ϰ ߴٰ 3 .GCڴ ȭǴ ڷγ19 Ȳ ù 縦 ߴ.ö GC
ϼ
2022-01-03
|
|
|
|
|
[] , ϴ ٲ۴ 'WEWE '
۷ι コɾ (Sanofi) ѱ -ƺƼ ڸ(ǥ ) Ľ(ǥ ĽĮ κ), コɾڸ(ǥ ĺ Ʈ)( Ƿ Ī) ٹ شȭϰ پ缺
ϼ
2022-01-03
|
|
|
|
|
[] GC, ҿ̿ 2 Ź
캴 ġ ü GCڰ ձ ̾ ִ.GC(ǥ ö) ¾ ȸ ȸ ü ڻ ҿ̿ 2 Źߴٰ 26 .GCڴ
ϼ
2021-12-27
|
|
|
|
|
[] GC, ǰɽǰ
GC(ǥ ) ڻ ǰɽǰ 귣 ǾƼ(Dr.PNT) ǰ ǰ ߴٰ 20 . 13 ᰡ 1 ִ
2021-12-20
|
|
|
|
|
[] ̼, 58ȸ "1õ ž"
̼(ȸ ) 迭 ̼ ڿΰ ְϰ ѱȸ ϴ 58ȸ Ŀ 1õ ž ߴٰ 6 . 7 1Ϻ 6 30ϱ 1Ⱓ
ϼ
2021-12-06
|
|
|
|
[] Ǽȸ, Ǽ Ư ȭ ȯ
ѱǼȸ(ȸ 輺) 25 Ǻΰ 2021 24 ǰåȸ( ɡ) Ǽ Ư ȡ 2022 1 ȯ ǻ縦 ǥߴ. ̹ Ƿ Ÿ缺,
ϼ
2021-12-01
|
|
|
|
|
[] ѱɴ, ð л鿡 ǰ ˰ŰƮ
ѱɴ 22 ȣ NGO ð Բ Ѻб 32 ð л鿡 ǰ 840 ˰ŰƮ 252 , ߴ.̹ ȸåȰ ǰ ð Ƶ ǰط
ϼ
2021-11-23
|
|
|
|
|
[] GC â, 20ȸ ѹα
GCڰ ڻ â 20ȸ ѹα ߴٰ 18 . û 17 ѱ 20 ȸ忡 Ǿ.â 13 1,959 3 7,909
2021-11-18
|
|
|
|
|
[] ͻ, ġ ̱ FDA Žž
ͻ(ǥ̻ ձ⿵) 汸 (CRIOM) ġ 'EC-18' ӻ 2 ̱ FDA Žž(Breakthrough Therapy Designation) ûߴٰ 10
ϼ
2021-11-10
|
|
|
|
|
[] GC, ġ ֻ ÷硯 㰡
캴 ġ ü GC(ǥ ö) ǰǾǰóκ ֻ ġ ÷硯 6 ̻ 2 ̸ ȹߴٰ 5 . ֻ ġ ɴ 㰡
ϼ
2021-11-05
|
|
|
|
|
[] ѱȭ, 'ܺ ν ' 系 ķ
-ȯ , ç ܺ ȯ ̰ ȯڿ ѱȭ(ǥ̻ ) 11 1 ܺ ν (Acromegaly Awareness Day) ¾
ϼ
2021-11-01
|
|
|
|
|
[] GC, 3б 715 41%
캴 ġ ü GCڴ 3б 濵(繫ǥ ) 4657, 715 ߴٰ 1 ߴ. ̴ Ⱓ 11%, 41% ̴.GC
ϼ
2021-11-01
|
|
|